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  Abstract  
This study aimed to assess the release of cardiac damage bi-
omarkers jointly with cardiac autonomic modulation after a 
mountain ultramarathon. Such knowledge and the possible rela-
tionship of these markers with race time is of primary interest to 
establish possible recommendations upon athletes' recovery and 
return to training following these competitions. Forty six athletes 
enrolled in the Penyagolosa Trails CSP115 race (118 km and a 
total positive elevation of 5439 m) took part in the study. N-ter-
minal pro-brain natriuretic peptide (NT-proBNP) and high-sensi-
tive cardiac troponin T (hs-TNT) concentrations as well as linear 
and nonlinear heart rate variability (HRV) were evaluated before 
and after the race. NT-proBNP and hs-TNT significantly in-
creased post-race; fifty percent of the finishers surpassed the Up-
per Reference Limit (URL) for hs-TNT while 87% exceeded the 
URL for NT-proBNP. Overall and vagally-mediated HRV were 
diminished and cardiac autonomic modulation became less com-
plex and more predictable following the race. More pronounced 
vagal modulation decreases were associated with higher levels of 
postexertional NT-proBNP. Moreover, rise in hs-TNT and NT-
proBNP was greater among faster runners, while pre-race overall 
and vagally-mediated HRV were correlated with finishing time. 
Participation in a 118-km ultratrail induces an acute release of 
cardiac damage biomarkers and a large alteration of cardiac auto-
nomic modulation. Furthermore, faster runners were those who 
exhibited a greater rise in those cardiac damage biomarkers. In 
light of these findings, an appropriate recovery period after ul-
traendurance races appears prudent and particularly important 
among better performing athletes. At the same time, HRV analy-
sis is shown as a promising tool to assess athletes' readiness to 
perform at their maximum level in an ultraendurance race. 
 
Key words: Heart rate variability, heart rate complexity, cardiac 
damage, ultratrail, performance, recovery.
  
Introduction 
 
The beneficial effects of moderate and regular exercise on 
overall health are irrefutable (Warburton et al., 2006); how-
ever, the acute and chronic consequences of prolonged and 
exhaustive endurance exercise remain unclear, especially 
on the heart (Abela and Sammut, 2017; Sharma et al., 
2015). Indeed, numerous studies have documented eleva-
tions in biomarkers consistent with cardiac damage (i.e., 
cardiac troponins [cTn]) in apparently healthy individuals 
following marathon and ultra-marathon races. A meta-
analysis which included 1120 endurance athletes from 26 
studies employing second and third-generation cTn assays, 
reported an incidence rate (i.e. cTn concentration above the 
Upper Reference Limit, defined as the 99th percentile of a 
healthy population, URL) of 47% (Shave et al., 2007). 
Moreover, several studies have observed concomitant tran-
sient abnormalities in both ventricular (Passaglia et al., 
2013; Vitiello et al., 2013) and atrial function (Wilhelm et 
al., 2014). This fact, together with the drastic rise in the 
popularity of ultra-distance mountain races over the last 
few years (Hoffman et al., 2010), has heightened concern 
among runners, scientists and clinicians alike. Hence, con-
sidering this scenario, it seems relevant to undertake more 
studies assessing the cardiac impact of ultraendurance 
races. 
Meanwhile, changes in cardiac autonomic activity 
have been postulated to reflect exercise-induced changes in 
cardiac performance and haemodynamics (Stanley et al., 
2013). However, research about the impact of ultraendur-
ance exercise on the autonomic control of the heart rate 
(HR) is still limited (Foulds et al., 2014; Gratze et al., 2005; 
Hautala et al., 2001; Scott et al., 2009), and only Scott et 
al. (2009) assessed HR variability (HRV) jointly with car-
diac damage biomarkers release (i.e., N-terminal pro-brain 
natriuretic peptide, NT-proBNP; cardiac troponin T, 
cTnT). Interestingly, in this latter study, although no sig-
nificant changes were noted in HRV (with the exception of 
mean HR) following the 160-km Western States Endur-
ance Run (WSER), authors found a significant positive 
correlation between delta changes in high frequency mod-
ulation of HRV measured in normalized units (HFnu) and 
NT-proBNP.  
Furthermore, none of the previous studies assessing 
the impact of ultraendurance exercise upon cardiac auto-
nomic modulation have employed nonlinear indices. Sev-
eral authors have argued that the evaluation of nonlinear 
oscillations in the HR signal (i.e. complexity and fractal 
properties) offers an additional qualitative insight into car-
diac autonomic modulation, characterized by less depend-
ency on HR and lower inter-individual and intra-individual 
variation (Nicolini et al., 2012). Indeed, changes in com-
plexity and fractal properties of HR dynamics have been 
previously reported in the absence of changes in HRV 
measures, suggesting that nonlinear methodologies not 
only  compliment  the  analysis of HRV but it may also be  
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more sensitive than the latter (Millar et al., 2009a).  
Similarly   to   the  inclusion  of  chaos  theory  and      
fractal mathematics in the assessment of HR dynamics, in 
the last years the laboratory technical improvements have 
led to the current availability of high-sensitivity (hs) assays 
to assess cardiac troponins. These assays are characterized 
by lower limits of detection and improved reliability com-
pared to second and third-generation cTn assays 
(Giannitsis et al., 2009). However, given to their recent in-
troduction in the field, only a small number of studies have 
measured hs-TNT following strenuous exercise (Vilela et 
al., 2014). NT-proBNP and hs-TNT are integral to the di-
agnosis of acute coronary syndromes (ACS) and conges-
tive heart failure (CHF); however, the significance of ele-
vations in these biomarkers in athletes in the absence of 
ACS or CHF remains uncertain (Donnellan and Phelan, 
2018). Therefore, the assessment of NT-proBNP and hs-
TNT jointly with HR dynamics following an ultraendur-
ance mountain race could contribute to a better understand-
ing of cardiac consequences of such extreme endurance 
events and thus enable establishing possible recommenda-
tions upon athletes' recovery and return to training follow-
ing these competitions. Our study hypothesis was that par-
ticipants would sustain a significant release of cardiac-spe-
cific biomarkers jointly with a cardiac autonomic impair-
ment. We also hypothesized that pre-race HR dynamics 
would be associated with performance. 
 
Methods 
 
Participants 
Forty six male recreational ultra-endurance athletes were 
recruited to participate in the study. Selected athletes were 
required to have previously completed at least one ultra-
marathon (>60 km). This research was developed at the 
Penyagolosa Trails CSP115 race in 2014 (May 17th - 18th), 
which hosted the 1st edition of the Spanish Ultra-Endurance 
Championship. The track consisted of 118 km, starting at 
an altitude of 40 m and finishing at 1280 m above the sea 
level, with a total positive and negative elevation of 5439 
and 4227 m respectively. All subjects were fully informed 
of the procedure and gave their written consent to partici-
pate. They were also allowed to withdraw from the study 
at will. A questionnaire was used to collect demographic 
information as well as training and competition history. 
The main characteristics of the sample are presented in Ta-
ble 1. The investigation was conducted according to the 
Declaration of Helsinki and approval for the project was 
obtained from the research Ethics Committee of the Uni-
versity Jaume I of Castellon. 
 
Assessment of cardiac autonomic modulation 
HR beat-to-beat data was acquired during 10 min of supine 
rest in the afternoon the day before the race and following 
race completion, in both cases before blood collection. Par-
ticipants were informed to avoid caffeine and exercise in 
the 12 h before pre-race testing and a large meal in the pre-
vious 4 h. Following the race, the initiation of HR record-
ing occurred within 5 min from crossing the finish line. In 
that time span, participants were allowed neither to drink 
nor to eat.  Measurements were  performed  using  a  Polar  
RS800 HR monitor together with a Polar Wearlink Wind 
electrode transmitter (Polar Electro, Kempele, Finland), af-
ter application of conductive gel as recommended by the 
manufacturer. This instrument has been previously vali-
dated for the accurate measurement of RR intervals in 
young and middle-aged men (Wallen et al., 2012). Respir-
atory rate was not controlled to not interfere in athletes’ 
recovery, although they were asked to avoid irregular res-
piration. Normal respiratory rate does not result in signifi-
cantly different heart rate-derived indices compared with 
controlled breathing (Bloomfield et al., 2001). 
 
Table 1. Final sample (n=46) main characteristics (mean±SD). 
Age (years) 42 ± 7.49 
Weight (kg) 74.06 ± 7.73
Height (m) 1.74 ± 0.05
BMI (kg/m2) 24.56 ± 1.94
Years since 1st Ultra-marathon (>60-km) 4.63 ± 3.97
Ultramarathons (>60-km) races before event %
1 37.2 
2 16.3 
3 9.3 
4 14 
5 4.7 
> 5 18.6 
Average weekly sessions 4.37 ± 1.45
Average weekly training volume (hours) %
< 12 48.8 
12 - 15 37.2 
16 - 20 9.3 
> 20 4.7 
Average weekly training volume (km) %
< 50 16.3 
50 - 75 46.5 
75 - 100 23.3 
100 - 150 9.3 
> 150 4.7 
BMI, Body Mass Index 
 
RR intervals were transferred to Polar Pro Trainer 5 
software (Polar Electro, Kempele, Finland) and afterwards 
analyzed using Kubios HRV Analysis Software 2.0 (The 
Biomedical Signal and Medical Imaging Analysis Group, 
University of Kuopio, Finland). The whole analysis pro-
cess was carried out by the same researcher to ensure con-
sistency (Martinez-Navarro et al., 2018). Artifacts were 
identified and corrected according to manufacturer’s 
recommendations (Tarvainen et al., 2008), and only those 
recordings with <1% of artefacts were considered. The 
following indices were obtained from the last 5-min seg-
ment of both recordings: mean HR; the standard deviation 
of normal RR intervals (SDNN) as a measure of overall 
variability and the root-mean-square difference of 
successive normal RR intervals (RMSSD) as a measure of 
vagal modulation; the short-term scaling exponent (4 to 11 
beats, α1) from Detrended Fluctuation Analysis to estimate 
sympathovagal balance and fractal correlation properties; 
and Sample Entropy (SampEn) to provide an indication of 
the complexity of the time-series under these circum-
stances (Nicolini et al., 2012; Tulppo et al., 2005). Time 
domain indices were chosen instead of spectral indices 
because of its greater intraindividual reproducibility (Al 
Haddad et al., 2011).  
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Assessment of cardiac damage biomarkers 
Blood samples were collected from an antecubital vein by 
venipuncture at baseline (in the afternoon the day before 
the race) and after completion of the ultra-endurance com-
petition (following the HR recording) using BD Vacutainer 
PST II tubes; then they were centrifuged at 3500 rpm for 
ten minutes and kept at 4°C during transport to NISA Rey 
Don Jaime Hospital for analysis of the biochemical varia-
bles. Hs-TNT was measured quantitatively with the new 
high-sensitive enzyme immunoassay based on electro-
chemiluminescence technology (ECLIA), using a Cobas 
e411 analyzer (Roche Diagnostics, Penzberg, Germany). 
Detailed descriptions of this assay have been previously 
published (Giannitsis et al., 2010). The Limit of the Blank 
(LoB) of this assay is 3 ng/L and the URL, defined as the 
99th percentile of a healthy population, 14 ng/L. The ap-
proximate hs-TnT equivalent to the upper limit of 30 ng/L 
for the 4th generation cTnT assay is 50 ng/L (Giannitsis et 
al., 2010). NT-proBNP was assessed with an Elecsys 
proBNP ECLIA using a Cobas 6000 e601 analyzer (Roche 
Diagnostics, Basel, Switzerland). The URL for NT-
proBNP was considered to be 125 ng/l (McMurray et al., 
2012). 
 
Statistical analysis 
 
Statistical analyses were carried out using the Statistical 
Package for the Social Sciences software (IBM SPSS Sta-
tistics for Windows, version 22.0, IBM Corp., Armonk, 
NY). After testing for normal distribution (Kolmogorov-
Smirnov test, with Lilliefor’s correction), SDNN, RMSDD 
and NT-proBNP were logarithmically transformed to al-
low parametric comparisons. Notwithstanding, data are 
provided as raw values (i.e. not logarithmically trans-
formed) to facilitate the interpretation of the results.  HR 
dynamics indices and lnNT-proBNP were compared be-
fore and after the race using Student's t-tests. Possible rela-
tionships between post-race cardiac damage biomarkers 
and HR dynamics indices with performance, demographic 
and training data were assessed using Pearson correlation 
analyses. The same statistical procedure was applied to an-
alyze possible associations between and pre-race and post-
race HR dynamics indices and cardiac damage biomarkers. 
Post-race values for cardiac damage biomarkers and HR 
dynamics indices for each subject were related to the indi-
vidual baseline level to define the delta scores (∆): 
 
∆(fold increase) = (post-race value – pre-race value)/pre-race value 
 
Due to the nature of hs-TNT data, pre-post changes 
were assessed on a case-by-case basis and values below the 
LoB (<3 ng/l) were set to 3 ng/l to calculate delta percent-
ages. The meaningfulness of the outcomes was estimated 
through the effect size (ES, means divided by the standard 
deviation): an ES<0.5 was considered small; between 0.5-
0.8, moderate; and greater than 0.8, large (Thomas et al., 
2005). Likewise, correlations >0.5 were considered large, 
0.3-0.5, moderate and <0.3, small. The significance level 
was set at p < 0.05 and data are presented as means and 
standard deviations (±SD). 
 
Results 
 
Thirty athletes successfully completed the race with an av-
erage finish time of 21 h 59 min ± 4 h 1 min. The finish-
ers/starters ratio for the subjects of the present study (i.e. 
65.2%) was similar to the ratio when all male race partici-
pants were considered (64.7%), whereas the average finish 
time was somewhat faster when all male race participants 
were considered (21 h 21 min ± 4 h 26 min). All levels of 
performance were represented in our sample as shown by 
their rank ranging from 30th to 288th place (of 294 male 
finishers). Unfortunately, 2 participants were excluded 
from HR dynamics analyses due to an excessive number of 
artifacts (>1%) in their HR recordings.  
 
 
 
 
 
b  
 
 
 Figure 1. Relationship between finishing time (x-axis) and 
cardiac biomarkers release (y-axis). Linear regression (R2) is 
included. 
 
Cardiac damage biomarkers 
The concentration of cardiac damage biomarkers measured 
in post-race samples was remarkably increased as com-
pared with values obtained on baseline specimens. At base-
line, concentrations of serum hs-TNT were negative (i.e., 
below the LoB) in 23 subjects and none participant dis-
played a value above the URL. After the race, 27 athletes 
(90%) showed measurable values of hs-TNT; 15 of those 
runners (50%) displayed values exceeding the URL but 
only 1 participant surpassed the threshold for suspicion of 
myocardial injury. The post-race range of concentrations 
varied from <3 (3 participants) to 78.1 ng/L. Change in hs-
TNT was largely and inversely associated with finishing 
time (r= -0.51; p < 0.01; see Figure 1) and a moderate in-
verse relationship was also found between changes in hs-
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TNT and SampEn (r = -0.38; p < 0.05). The exclusion of 
the only participant which exceeded the 50 ng/L threshold 
increased the magnitude of the associations between ∆ hs-
TNT and both finishing time (r = -0.67; p < 0.01) and ∆ 
SampEn (r = -0.49; p < 0.01). 
At baseline, mean NT-proBNP was 20.90 ± 15.84 
ng/L. After the CSP115 race, NT-proBNP levels were sig-
nificantly and largely higher (443 ± 280.61 ng/L, p < 0.01, 
ES = 2.16), with a post-race range of NT-proBNP concen-
trations from 37.3 to 1109 ng/L. Pre-race, none athlete had 
NT-proBNP concentrations which exceeded the URL for 
healthy subjects, while 26 participants (86.7%) had post-
race levels above this clinical threshold. Change in NT-
proBNP was largely and inversely correlated with finishing 
time (r = -0.60; p < 0.01; see Figure 1). A moderate inverse 
relationship was also found between changes in NT-
proBNP and lnRMSSD (r = -0.41; p < 0.05). On the con-
trary, baseline NT-proBNP was unrelated to ∆ NT-proBNP 
or performance, and change in cardiac damage biomarkers 
(i.e., ∆ hs-TNT nor ∆ NT-proBNP) was neither correlated 
to age or training-related variables (i.e. years since 1st ultra-
marathon and average training weekly sessions); although 
average training weekly sessions showed a tendency to-
wards significance with ∆ NT-proBNP (r = 0.32; p = 0.09). 
Besides, ∆ NT-proBNP and ∆ hs-TNT were positive and 
largely correlated (r = 0.65; p < 0.01). 
 
 
 
 
 
b 
 
 
 
 
Figure 2. Relationship between finishing time (x-axis) and 
baseline HRV (y-axis). Linear regression (R2) is included. 
 
Cardiac autonomic modulation 
HR and both linear and nonlinear HR dynamics indices sig-
nificantly changed from pre-race to post-race. HR was    
significantly and largely increased (58.81 ± 7.89 vs 76.31 
± 9.63 bpm, p < 0.01, ES=2.02) whereas overall HRV (i.e. 
lnSDNN) and vagally-mediated HRV (i.e. lnRMSSD) 
were significantly and largely decreased post-race (44.51 ± 
19.11 vs 25.83 ± 14.68 ms, p < 0.01, ES = -1.20; 43.58 ± 
23.92 vs 19.92 ± 14.16 ms, p < 0.01, ES = -1.39). There 
was also a significant and large increase of α1 (1.12 ± 0.25 
vs 1.43 ± 0.24, p < 0.01, ES = 1.32) concomitantly with a 
significant and large reduction of SampEn (1.71 ± 0.27 vs 
1.48 ± 0.28, p < 0.01, ES = -0.85). Pre-race lnSDNN and 
lnRMSSD were moderately and inversely correlated with 
finishing time (r = -0.46 and r= -0.40; p < 0.05; see Figure 
2). Besides, a moderate relationship was found between 
finishing time and change in HR and SampEn (r = -0.43 
and r = 0.44; p < 0.05). Finally, all linear and nonlinear HR 
dynamics indices at baseline were inversely correlated with 
their respective pre-post change (r value range = -0.82 to -
0.39; p < 0.05).  
 
Discussion 
 
The results of the present study demonstrate that ultra-dis-
tance mountain races, such as Penyagolosa Trails CSP115, 
induce a great increase in cardiac damage biomarkers       
together with a large alteration of cardiac autonomic mod-
ulation.  
 
Cardiac damage biomarkers 
A large significant increase was recorded in NT-proBNP 
(27.32 ± 20.77-fold rise; 20.90 ± 15.84 vs. 443 ± 280.61 
ng/L) and more than 86% of the participants displayed 
post-race levels of NT-proBNP above the URL. Previous 
studies involving ultraendurance events found similar re-
sults to ours (Ohba et al., 2001; Scott et al., 2009; Stelzer 
et al., 2015); whereas following shorter races (i.e., road 
half-marathon and marathon) there has been described a 
smaller release of NT-proBNP (Shave et al., 2007). Alto-
gether, our results endorse previous suggestion that rise in 
NT-proBNP as a consequence of prolonged strenuous ex-
ercise seems to be related to the duration of the race 
(Scharhag et al., 2005; Serrano-Ostariz et al., 2011; Shave 
et al., 2007). 
Fifty percent of the participants in our study sur-
passed the URL for hs-TNT following the race. As noted 
in the introduction, only a handful of studies have assessed 
high-sensitivity cardiac troponins following strenuous ex-
ercise. During the 216-km Badwater Ultra-marathon 4 out 
of 10 runners displayed hs-TNT concentrations above the 
URL (Giannitsis et al., 2009); whereas the prevalence of 
post-road marathon values exceeding the URL ranged be-
tween 86 and 94% (Vilela et al., 2014). Our data thus rein-
force previous assumption that the proportion of troponin-
positive participants in ultraendurance events is lower than 
that reported in shorter distances (i.e. road marathons), 
probably due to the lower exercise intensities in these com-
petitions (Shave et al., 2007). Actually, albeit measured 
with the less accurate 2nd and 3rd generation cTn assays, 
following the 161-km WSER only 20% of the athletes ex-
ceeded the URL (Scott et al., 2009) and barely two runners 
did it (16.7%) after completing a 24-h ultra-marathon 
(Passaglia et al., 2013). 
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Furthermore,  the  observation  that  cTn  is  signifi- 
cantly risen following common recreational physical activ-
ities such as a 1-h kettlebell or a spinning class (Duttaroy 
et al., 2012; Savukoski et al., 2015) suggest that troponin 
elevations are common following short but vigorous exer-
cise and not necessarily a product of a prolonged and ex-
haustive effort. Indeed, although some abnormalities in 
ventricular and atrial function have been observed in sub-
jects acutely after endurance exercise (Passaglia et al., 
2013; Vitiello et al., 2013; Wilhelm et al., 2014), both fol-
low-up studies (Scharhag et al., 2006) and cardiac mag-
netic resonance imaging examinations (O'Hanlon et al., 
2010) indicate that there is no evidence that these acute ef-
fects may translate into an irreversible cardiac damage. Be-
sides, the fact that normalization of cTn concentrations has 
been demonstrated to occur within 24h after exercise rein-
forces the physiological, rather than pathological, meaning 
of exercise-derived cTn release (Shave et al., 2010). 
Nevertheless, the association found between finish-
ing time and change in both NT-proBNP and hs-TNT im-
plies that faster runners released greater amounts of cardiac 
damage biomarkers during the race. The same relationship 
between finishing time and cardiac troponin I has been re-
ported following the 166-km Ultra Trail du Mont Blanc 
(Vitiello et al., 2013) and the 161-km Leadville (Khodaee 
et al., 2015). Besides, exercise intensity has been demon-
strated to be an important factor to trigger the release of 
cardiac troponins (Serrano-Ostariz et al., 2011; Shave et 
al., 2007). Therefore, it may be reasonable to think that 
faster runners sustain a greater cardiac damage during an 
ultraendurance event. However, exercise-induced NT-
proBNP production has been suggested to have cytoprotec-
tive and growth-regulating effects (Giannitsis et al., 2009; 
Scharhag et al., 2005); similarly, the release of cTn during 
exercise has been attributed in the last years to physiologic 
adaptive and reversible damage rather than pathological ir-
reversible damage (Donnellan and Phelan, 2018; 
Giannitsis et al., 2009; Shave et al., 2010); hence, we spec-
ulate that greater release of cardiac damage biomarkers in 
faster runners is reflective of the capacity to stress their car-
diovascular system to a greater extent during exercise. 
Moreover, very recently Legaz-Arrese et al. (2015) have 
reported that a 14-week endurance training intervention re-
sulted in better performance and higher values of hs-TNT 
following a 60-min running time trial. These authors sug-
gested that post-intervention higher values of hs-TNT 
could reflect a physiological heart adaptation to exercise 
training stimulus, similar to what happens with heart size, 
and thus should not be interpreted as a risk or hazardous 
consequence of achieving a greater training status. 
The large and positive relationship found between 
∆ NT-proBNP and ∆ hs-TNT adds more controversy to an 
already debated topic. Following a timeline, Ohba et al. 
(2001) formerly showed a significant correlation between 
NT-proBNP and cTnT after running a 100-km ultra-mara-
thon and suggested that this relationship implied that exer-
cise-induced release of cTnT was mainly attributable to 
myocardial cell necrosis. On the contrary, most of the sub-
sequent reports employing more specific cTnT assays (i.e., 
3rd generation) did not find such a relationship (Scharhag 
et al., 2005). However, other studies assessing hs-TNT 
have shown both correlated (Giannitsis et al., 2009) and 
uncorrelated outcomes (Scherr et al., 2011). Therefore, it 
remains an open question whether there exists a relation-
ship or not between the exercise-induced release of those 
two biomarkers. In either case, that association would not 
involve evidence of myocardial cell necrosis as formerly 
suggested by Ohba et al. (2001), but rather an interrelated 
physiologic response to cardiac stress imposed by strenu-
ous exercise, accordingly with the hypothesis stated in the 
preceding paragraph. 
 
Cardiac autonomic modulation 
As far as we are concerned, this is the first study to assess 
nonlinear HR dynamics following an ultraendurance event. 
Our results showed that cardiac autonomic modulation be-
came less complex and more predictable following the race 
(i.e., lower SampEn and higher α1). Previous investigations 
assessing the immediate recovery from short-lasting high-
intensity workouts have achieved similar results (Blasco-
Lafarga et al., 2013; Goulopoulou et al., 2009; Millar et al., 
2009b), although in the study from Blasco-Lafarga et al. 
(2013) SampEn showed no change following a supramax-
imal Judo test. Interestingly, the magnitude of the change 
in SampEn was the smallest among linear and nonlinear 
indices in our research; thus it may be argued that complex-
ity properties of HR behaviour are more resilient (i.e., com-
pared to vagal and sympathetic drive indices) to exercise 
stress. In either case, the extreme duration of an ultradis-
tance mountain race (21 h 59 min ± 4 h 4 min) appears to 
induce a similar immediate alteration in HR dynamics as a 
short-lasting but high-intensity workout. Further studies 
should delve into the recovery timeline of nonlinear HR 
dynamics following an ultraendurance event.  
At the same time, our significant and large reduc-
tion in both overall and vagally mediated HRV coincides 
with previous studies involving mountain marathon races 
(Bernardi et al., 1997; Murrell et al., 2007) and ultraendur-
ance events (Foulds et al., 2014; Gratze et al., 2005; 
Hautala et al., 2001). Only one study has reported non-sta-
tistical changes in HRV following an ultraendurance event 
(160-km WSER; Scott et al., 2009). Moreover, our increase 
in α1, which is considered also a sympathovagal balance 
index (Tulppo et al., 2005), is consistent with post-race 
sympathetic predominance observed in previous studies 
using spectral domain indices (Bernardi et al., 1997; Foulds 
et al., 2014; Gratze et al., 2005; Murrell et al., 2007).  
In addition, cardiac damage and reduction in vagal 
modulation seems to be interrelated, so that those athletes 
who showed the greatest post-race reductions in parasym-
pathetic modulation (i.e., lnRMSSD) also displayed the 
greatest increases in NT-proBNP. A similar pattern (a 
larger HRV reduction in runners with higher post-race hs-
TNT) has been described following a 30-km cross-country 
running race (Aagaard et al., 2014). However, it opposes to 
the results of Scott et al. (2009), who found a positive as-
sociation between changes in HFnu and NT-proBNP fol-
lowing a 160-km ultratrail. The reason for the discrepancy 
with this latter study may lie in the lower intraindividual 
reproducibility of spectral domain indices and lower 
reliability of relative indices (i.e., expressed in normalized 
units)  in  situations  of low total spectral power (i.e., post- 
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exercise) (Al Haddad et al., 2011). 
Our outcomes also showed a significant relation-
ship between pre-race cardiac autonomic modulation, post-
race HRV delta scores and performance; namely, those ath-
letes with higher baseline overall and vagally-mediated 
HRV showed larger changes in those variables, and more-
over, achieved a greater performance in the race. A previ-
ous study failed to find any relationship between baseline 
HRV (i.e. HFnu and LFnu indices) and performance in an 
Ironman (Gratze et al., 2005). Nevertheless, our results are 
in accordance with previous studies (Blasco-Lafarga et al., 
2013; Buchheit and Gindre, 2006; Cataldo et al., 2018) and 
the “autonomic resource hypothesis” proposed by 
Hynynen et al. (2008), which suggests that a better baseline 
profile of cardiac autonomic modulation allows further us-
age of autonomic resources during self-paced exercise and 
contribute to a better performance. Further studies should 
elucidate whether a better baseline profile of cardiac auto-
nomic modulation is also related to a faster intermediate 
and long-term recovery (i.e., from 1h after the race on-
wards) following an ultraendurance event.  
 
Conclusion 
 
Participation in a 118-km ultratrail induces an acute release 
of cardiac damage biomarkers together with a large altera-
tion of both linear and nonlinear indices of cardiac auto-
nomic modulation. Furthermore, the magnitude of cardiac 
damage biomarkers increase and cardiac autonomic modu-
lation disturbance appear to be interrelated and greater 
among faster runners. This leads us to suggest that faster 
runners are able to stress their cardiovascular system to a 
greater extent during self-paced prolonged endurance ex-
ercises. In light of these findings, an appropriate recovery 
period after ultraendurance races seems prudent and partic-
ularly important among better performing athletes. 
Finally, our results show that those athletes with 
higher baseline overall and vagally-mediated HRV dis-
played larger pre-post changes in those variables and 
achieve faster finishing times in the race; therefore, HRV 
analysis is proposed as a coach's tool to assess athletes' 
readiness to perform at their maximum level in an ul-
traendurance race. 
 
Limitations 
We recognise that a single assessment immediately post-
exercise might not reflect peak concentrations of cardiac 
damage biomarkers and does not allow any inference on 
the recovery timeline of cardiovascular alterations found 
(i.e. cardiac autonomic impairment and cardiac damage) 
(Legaz-Arrese et al., 2015; Stanley et al., 2013); however, 
obtaining further sampling (i.e. blood draws and HR re-
cordings) was extremely difficult and even unethical due 
to the location of the finish line (Penyagolosa Trails 
CSP115 is a non-circular race and start and finish line are 
80-km apart). 
 
Acknowledgements  
Current research could be carried out thanks to the collaboration of 
Vithas-Nisa Hospitals group and "Cátedra Endavant Villarreal CF de l'Es-
port". Authors are also grateful to Penyagolosa Trails organization, ath-
letes who participate in the study and volunteers. Experiments performed 
during this research comply with the current laws of Spain. The authors 
have no conflicts of interests to declare.  
 
References  
 
Aagaard, P., Sahlen, A., Bergfeldt, L. and Braunschweig, F. (2014) Heart 
rate and its variability in response to running-associations with 
troponin. Medicine Science Sports Exercise 46, 1624-1630, Aug. 
Abela, M. and Sammut, L. (2017) Cardiac troponin: more than meets the 
eye. Postgraduate Medical Journal 93, 762-765, Dec. 
Al Haddad, H., Laursen, P.B., Chollet, D., Ahmaidi, S. and Buchheit, M. 
(2011) Reliability of resting and postexercise heart rate 
measures. International Journal Sports Medicine 32, 598-605, 
Aug. 
Bernardi, L., Passino, C., Robergs, R. and Appenzeller, O. (1997) Acute 
and persistent effects of a 46-kilometer wilderness trail run at 
altitude: cardiovascular autonomic modulation and baroreflexes. 
Cardiovascular Research 34, 273-80, May. 
Blasco-Lafarga, C., Martinez-Navarro, I. and Mateo-March, M. (2013) Is 
baseline cardiac autonomic modulation related to performance 
and physiological responses following a supramaximal Judo 
test? PLoS One 8, e78584. 
Bloomfield, D.M., Magnano, A., Bigger, J.T., Jr., Rivadeneira, H., 
Parides, M. and Steinman, R.C. (2001) Comparison of 
spontaneous vs. metronome-guided breathing on assessment of 
vagal modulation using RR variability. American Journal 
Physiology-Heart Circulatory Physiology 280, H1145-1150. 
Buchheit, M. and Gindre, C. (2006) Cardiac parasympathetic regulation: 
respective associations with cardiorespiratory fitness and 
training load. American Journal Physiology-Heart Circulatory 
Physiology 291, H451-8, Jul. 
Cataldo, A., Bianco, A., Paoli, A., Cerasola, D., Alagna, S., Messina, G., 
Zangla, D. and Traina, M. (2018) Resting sympatho-vagal 
balance is related to 10 km running performance in master 
endurance athletes. European Journal of Translational Myology 
28, 7051, Jan 12. 
Donnellan, E. and Phelan, D. (2018) Biomarkers of Cardiac Stress and 
Injury in Athletes: What Do They Mean? Current Heart Failure 
Reports 15, 116-122, Apr. 
Duttaroy, S., Thorell, D., Karlsson, L. and Borjesson, M. (2012) A single-
bout of one-hour spinning exercise increases troponin T in 
healthy subjects. Scandinavian Cardiovascular Journal 46, 2-6. 
Foulds, H.J., Cote, A.T., Phillips, A.A., Charlesworth, S.A., Bredin, S.S., 
Burr, J.F., Drury, C.T., Ngai, S., Fougere, R.J., Ivey, A.C. and 
Warburton, D.E. (2014) Characterisation of baroreflex 
sensitivity of recreational ultra-endurance athletes. European 
Journal Sport Science 14, 686-694. 
Giannitsis, E., Kurz, K., Hallermayer, K., Jarausch, J., Jaffe, A.S. and 
Katus, H.A. (2010) Analytical validation of a high-sensitivity 
cardiac troponin T assay. Clinical Chemistry 56, 254-261, Feb. 
Giannitsis, E., Roth, H.J., Leithauser, R.M., Scherhag, J., Beneke, R. and 
Katus, H.A. (2009) New highly sensitivity assay used to measure 
cardiac troponin T concentration changes during a continuous 
216-km marathon. Clinical Chemistry 55, 590-592, Mar. 
Goulopoulou, S., Fernhall, B. and Kanaley, J.A. (2009) Hemodynamic 
responses and linear and non-linear dynamics of cardiovascular 
autonomic regulation following supramaximal exercise. 
Europeam Journal Applied Physiology 105, 525-531, Mar. 
Gratze, G., Rudnicki, R., Urban, W., Mayer, H., Schlogl, A. and Skrabal, 
F. (2005) Hemodynamic and autonomic changes induced by 
Ironman: prediction of competition time by blood pressure 
variability. Journal Applied Physiology (1985) 99, 1728-1735, 
Nov. 
Hautala, A., Tulppo, M.P., Makikallio, T.H., Laukkanen, R., Nissila, S. 
and Huikuri, H.V. (2001) Changes in cardiac autonomic 
regulation after prolonged maximal exercise. Clinical 
Physiology 21, 238-245, Mar. 
Hoffman, M.D., Ong, J.C. and Wang, G. (2010) Historical analysis of 
participation in 161 km ultramarathons in North America. 
International Journal History Sport 27, 1877-91. 
Hynynen, E., Uusitalo, A., Konttinen, N. and Rusko, H. (2008) Cardiac 
autonomic responses to standing up and cognitive task in 
overtrained athletes. International Journal Sports Medicine 29, 
552-558, Jul. 
Khodaee, M., Spittler, J., VanBaak, K., Changstrom, B.G. and Hill, J.C. 
(2015) Effects of Running an Ultramarathon on Cardiac, 
Martínez-Navarro et al.
  
 
 
621
Hematologic, and Metabolic Biomarkers. International Journal 
Sports Medicine 36, 867-871, Nov. 
Legaz-Arrese, A., Lopez-Laval, I., George, K., Puente-Lanzarote, J.J., 
Mayolas-Pi, C., Serrano-Ostariz, E., Revilla-Marti, P., Moliner-
Urdiales, D. and Reverter-Masia, J. (2015) Impact of an 
endurance training program on exercise-induced cardiac 
biomarker release. American Journal Physiology-Heart 
Circulatory Physiology 308, H913-20, Apr 15. 
Martinez-Navarro, I., Chiva-Bartoll, O., Hernando, B., Collado, E., 
Porcar, V. and Hernando, C. (2018) Hydration Status, Executive 
Function, and Response to Orthostatism After a 118-km 
Mountain Race: Are They Interrelated? Journal Strength 
Conditioning Research 32, 441-449, Feb. 
McMurray, J.J., Adamopoulos, S., Anker, S.D., Auricchio, A., Bohm, M., 
Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., Gomez-
Sanchez, M.A., Jaarsma, T., Kober, L., Lip, G.Y., Maggioni, 
A.P., Parkhomenko, A., Pieske, B.M., Popescu, B.A., Ronnevik, 
P.K., Rutten, F.H., Schwitter, J., Seferovic, P., Stepinska, J., 
Trindade, P.T., Voors, A.A., Zannad, F., Zeiher, A., Bax, J.J., 
Baumgartner, H., Ceconi, C., Dean, V., Deaton, C., Fagard, R., 
Funck-Brentano, C., Hasdai, D., Hoes, A., Kirchhof, P., Knuuti, 
J., Kolh, P., McDonagh, T., Moulin, C., Reiner, Z., Sechtem, U., 
Sirnes, P.A., Tendera, M., Torbicki, A., Vahanian, A., 
Windecker, S., Bonet, L.A., Avraamides, P., Ben Lamin, H.A., 
Brignole, M., Coca, A., Cowburn, P., Dargie, H., Elliott, P., 
Flachskampf, F.A., Guida, G.F., Hardman, S., Iung, B., Merkely, 
B., Mueller, C., Nanas, J.N., Nielsen, O.W., Orn, S., Parissis, J.T. 
and Ponikowski, P. (2012) ESC guidelines for the diagnosis and 
treatment of acute and chronic heart failure 2012: The Task 
Force for the Diagnosis and Treatment of Acute and Chronic 
Heart Failure 2012 of the European Society of Cardiology. 
Developed in collaboration with the Heart Failure Association 
(HFA) of the ESC. European Journal Heart Failure 14, 803-
869, Aug. 
Millar, P.J., Rakobowchuk, M., Adams, M.M., Hicks, A.L., McCartney, 
N. and MacDonald, M.J. (2009a) Effects of short-term training 
on heart rate dynamics in individuals with spinal cord injury. 
Autonomic Neuroscience 150, 116-121, Oct 5. 
Millar, P.J., Rakobowchuk, M., McCartney, N. and MacDonald, M.J. 
(2009b) Heart rate variability and nonlinear analysis of heart rate 
dynamics following single and multiple Wingate bouts. Applied 
Physiology Nutrition Metabolism 34, 875-883, Oct. 
Murrell, C., Wilson, L., Cotter, J.D., Lucas, S., Ogoh, S., George, K. and 
Ainslie, P.N. (2007) Alterations in autonomic function and 
cerebral hemodynamics to orthostatic challenge following a 
mountain marathon. Journal Applied Physiology (1985) 103, 88-
96, Jul. 
Nicolini, P., Ciulla, M.M., De Asmundis, C., Magrini, F. and Brugada, P. 
(2012) The prognostic value of heart rate variability in the 
elderly, changing the perspective: from sympathovagal balance 
to chaos theory. Pacing Clinical Electrophysiology 35, 622-638, 
May. 
O'Hanlon, R., Wilson, M., Wage, R., Smith, G., Alpendurada, F.D., 
Wong, J., Dahl, A., Oxborough, D., Godfrey, R., Sharma, S., 
Roughton, M., George, K., Pennell, D.J., Whyte, G. and Prasad, 
S.K. (2010) Troponin release following endurance exercise: is 
inflammation the cause? a cardiovascular magnetic resonance 
study. Journal Cardiovascular Magnetic Resonance 12, 38. 
Ohba, H., Takada, H., Musha, H., Nagashima, J., Mori, N., Awaya, T., 
Omiya, K. and Murayama, M. (2001) Effects of prolonged 
strenuous exercise on plasma levels of atrial natriuretic peptide 
and brain natriuretic peptide in healthy men. American Heart 
Journal 141, 751-758, May. 
Passaglia, D.G., Emed, L.G., Barberato, S.H., Guerios, S.T., Moser, A.I., 
Silva, M.M., Ishie, E., Guarita-Souza, L.C., Costantini, C.R. and 
Faria-Neto, J.R. (2013) Acute effects of prolonged physical 
exercise: evaluation after a twenty-four-hour ultramarathon. 
Arquivos Brasileiros Cardiologia 100, 21-28, Jan. 
Savukoski, T., Mehtala, L., Lindahl, B., Venge, P. and Pettersson, K. 
(2015) Elevation of cardiac troponins measured after 
recreational resistance training. Clinical Biochemistry 48, 803-6, 
Aug. 
Scott, J.M., Esch, B.T., Shave, R., Warburton, D.E., Gaze, D. and George, 
K. (2009) Cardiovascular consequences of completing a 160-km 
ultramarathon. Medicine Science Sports Exercise 41, 26-34, Jan. 
Scharhag, J., Herrmann, M., Urhausen, A., Haschke, M., Herrmann, W. 
and Kindermann, W. (2005) Independent elevations of N-
terminal pro-brain natriuretic peptide and cardiac troponins in 
endurance athletes after prolonged strenuous exercise. American 
Heart Journal 150, 1128-1134, Dec. 
Scharhag, J., Urhausen, A., Schneider, G., Herrmann, M., Schumacher, 
K., Haschke, M., Krieg, A., Meyer, T., Herrmann, W. and 
Kindermann, W. (2006) Reproducibility and clinical 
significance of exercise-induced increases in cardiac troponins 
and N-terminal pro brain natriuretic peptide in endurance 
athletes. European Journal Cardiovascular Prevention 
Rehabilitation 13, 388-397, Jun. 
Scherr, J., Braun, S., Schuster, T., Hartmann, C., Moehlenkamp, S., 
Wolfarth, B., Pressler, A. and Halle, M. (2011) 72-h kinetics of 
high-sensitive troponin T and inflammatory markers after 
marathon. Medicine Science Sports Exercise 43, 1819-1827, Oct. 
Serrano-Ostariz, E., Terreros-Blanco, J.L., Legaz-Arrese, A., George, K., 
Shave, R., Bocos-Terraz, P., Izquierdo-Alvarez, S., Bancalero, 
J.L., Echavarri, J.M., Quilez, J., Aragones, M.T. and Carranza-
Garcia, L.E. (2011) The impact of exercise duration and intensity 
on the release of cardiac biomarkers. Scandinavian Journal 
Medicine Science Sports 21, 244-249, Apr. 
Sharma, S., Merghani, A. and Mont, L. (2015) Exercise and the heart: the 
good, the bad, and the ugly. European Heart Journal 36, 1445-
53, Jun 14. 
Shave, R., Baggish, A., George, K., Wood, M., Scharhag, J., Whyte, G., 
Gaze, D. and Thompson, P.D. (2010) Exercise-induced cardiac 
troponin elevation: evidence, mechanisms, and implications. 
Journal American College Cardiology 56, 169-176, Jul 13. 
Shave, R., George, K.P., Atkinson, G., Hart, E., Middleton, N., Whyte, 
G., Gaze, D. and Collinson, P.O. (2007) Exercise-induced 
cardiac troponin T release: a meta-analysis. Medicine Science 
Sports Exercise 39, 2099-2106, Dec. 
Stanley, J., Peake, J.M. and Buchheit, M. (2013) Cardiac parasympathetic 
reactivation following exercise: implications for training 
prescription. Sports Medicine 43, 1259-1277, Dec. 
Stelzer, I., Kropfl, J.M., Fuchs, R., Pekovits, K., Mangge, H., Raggam, 
R.B., Gruber, H.J., Pruller, F., Hofmann, P., Truschnig-Wilders, 
M., Obermayer-Pietsch, B., Haushofer, A.C., Kessler, H.H. and 
Machler, P. (2015) Ultra-endurance exercise induces stress and 
inflammation and affects circulating hematopoietic progenitor 
cell function. Scandinavian Journal Medicine Science Sports 25, 
e442-450, Oct. 
Tarvainen, M., Niskanen, J., Lipponen, J., Ranta-aho, P. and Karjalainen, 
P. (2008). Kubios HRV—A Software for Advanced Heart Rate 
Variability Analysis. In: 4th European Conference of the 
International Federation for Medical and Biological 
Engineering, Heidelberg, S.B., Ed, Springer, Antwerp, Belgium, 
pp. 1022-1025. 
Thomas, J., Nelson, J. and Silverman, S. (2005) Research Methods in 
Physical Activity. Champaign: Human Kinetics. 
Tulppo, M.P., Kiviniemi, A.M., Hautala, A.J., Kallio, M., Seppanen, T., 
Makikallio, T.H. and Huikuri, H.V. (2005) Physiological 
background of the loss of fractal heart rate dynamics. Circulation 
112, 314-319, Jul 19. 
Vilela, E.M., Bastos, J.C., Rodrigues, R.P. and Nunes, J.P. (2014) High-
sensitivity troponin after running--a systematic review. 
Netherlands Journal Medicine 72, 5-9, Jan. 
Vitiello, D., Rupp, T., Bussiere, J.L., Robach, P., Polge, A., Millet, G.Y. 
and Nottin, S. (2013) Myocardial damages and left and right 
ventricular strains after an extreme mountain ultra-long duration 
exercise. International Journal Cardiology 165, 391-392, May 
10. 
Wallen, M.B., Hasson, D., Theorell, T., Canlon, B. and Osika, W. (2012) 
Possibilities and limitations of the Polar RS800 in measuring 
heart rate variability at rest. European Journal Applied 
Physiology 112, 1153-1165, Mar. 
Warburton, D.E., Nicol, C.W. and Bredin, S.S. (2006) Health benefits of 
physical activity: the evidence. Canadian Medical Association 
Journal 174, 801-809, Mar 14. 
Wilhelm, M., Zueger, T., De Marchi, S., Rimoldi, S.F., Brugger, N., 
Steiner, R., Stettler, C., Nuoffer, J.M., Seiler, C. and Ith, M. 
(2014) Inflammation and atrial remodeling after a mountain 
marathon. Scandinavian Journal Medicine Science Sports 24, 
519-525, Jun. 
 
HRV & Cardiac Biomarkers in Ultratrail 
  
 
622 
 
Key points 
 
 Faster runners were those who exhibited a greater rise 
in cardiac damage biomarkers (hs-TNT and NT-
proBNP). 
 An appropriate recovery period after ultraendurance 
races appears prudent and particularly important 
among better performing athletes. 
 HRV analysis is shown as a promising tool to assess 
athletes' readiness to perform at their maximum level 
in an ultraendurance race. 
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